Angewandte Chemie Paper Demonstrates PCC Ability to Enter Cells and Inhibit Botulinum Neurotoxin with Remarkable Binding Ability and Specificity

Angewandte Chemie (April 29, 2015) [Read more…] … [Read more]

Landmark Indi Molecular® Publication in Nature Chemistry Suggests PCC Binding Technology May Enable Therapeutics for Previously Undruggable Targets Based on Mutations of A Single Amino Acid

CULVER CITY, CA – (April 13, 2015) – Researchers at Caltech and Indi Molecular announced today a landmark publication in Nature Chemistry suggesting that the PCC (protein catalyzed capture) agent binding technology may enable the creation of highly … [Read more]

GenomeWeb – Indi Molecular Inks PCC Development Deal with Sigma, But Main Focus Now on Therapeutics

GenomeWeb | Dec 19, 2014 | Adam Bonislawski "As we have talked to pharmaceutical companies, it has become very clear that their interest is in super-binding molecules that can target very low abundance therapeutic targets, things that are really … [Read more]

Indi Molecular® and Sigma-Aldrich® Establish Collaboration to Explore Use of PCC Technology in Biological Tools

Press Release | 17 December 2014 CULVER CITY, CA -- Indi Molecular, the maker of a synthetic replacement for monoclonal antibodies, today announced that it has entered into a co-development agreement with Sigma-Aldrich to explore the use of Indi … [Read more]

Dr. Doug Fisher to Speak at Life Sciences Summit

Dr. Doug Fisher, to Speak at Life Sciences Summit October 29, 2014 | New York, NY | … [Read more]

BioCentury – Indi Molecular: Building better binders

BioCentury | 31 March 2014 | Emily Cukier-Meisner "We've been able to create a completely synthetic approach to building binding molecules," said Albert Luderer, CEO [PDF] … [Read more]

Indi Molecular Expands Seed Round to $1.8 Million with Additional $300 from Asset Management Ventures

CULVER CITY, CA -- (December 10, 2013) -- Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised an additional $300,000 from a new investor, Asset Management Ventures. With this investment, the … [Read more]

Indi Molecular Launches with $1.5 Million Seed Round Led by InterWest Partners

September 20, 2013 – Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised a $1.5 million seed round led by InterWest Partners and joined by several angel investors. The funds will be used to … [Read more]

Obama honors biotech pioneer Lee Hood

Puget Sound Business Journal | 4 January 2013 | Patti Payne
 “Dr. Leroy ‘Lee’ Hood, co-founder and president of the Seattle-based Institute for Systems Biology, has been chosen to receive the highest award bestowed upon scientists by the United … [Read more]

Integrated Diagnostics® Launches Imaging Division to Create PET Imaging Probes

Press Release | 13 June 2012 SEATTLE – Integrated Diagnostics (InDi®), an emerging leader in molecular diagnostics, today announced that the company has launched a new operating division, InDi Imaging™, that is creating a new generation of PET … [Read more]